Frontiers in Genome Editing 2025
Top Research Directions
The 4 research directions with Frontiers in Genome Editing 2025 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.
| # | Direction | Papers | Share |
|---|---|---|---|
| 1 | Engineering Precision Vehicles for Targeted RNA Delivery | 1 | 100.0% |
| 2 | Mapping and Bridging Disciplinary Fragmentation | 1 | 100.0% |
| 3 | Mapping Knowledge Domains with Bibliometric Analysis | 1 | 100.0% |
| 4 | The Aging Prevalence Paradox in Global Health Burden | 1 | 100.0% |
Download all directions as CSV
Institutions
Institutions credited by Frontiers in Genome Editing 2025 papers: a paper credits every institution named in its affiliations, once. 5 institutions share 1 credited papers.
| # | Institution | Papers | Share |
|---|---|---|---|
| 1 | 042pgcv68 | 1 | 100.0% |
| 2 | Arc Research Institute | 1 | 100.0% |
| 3 | Chengdu University of Traditional Chinese Medicine | 1 | 100.0% |
| 4 | Sichuan University | 1 | 100.0% |
| 5 | West China Hospital of Sichuan University | 1 | 100.0% |
Download all institutions as CSV
About this data
Papers. Frontiers in Genome Editing 2025 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.
Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.
Data. Counts come from Lacuna’s data build of 2026-11-18 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Frontiers in Genome Editing 2025”, https://lacuna.tiptreesystems.com/venue/frontiers-in-genome-editing/2025.
Papers
| Title |
|---|
| Mapping the therapeutic landscape of CRISPR-Cas9 for combating age-related diseases |